Central Line Study

Launched by MONTEFIORE MEDICAL CENTER · Sep 6, 2022

Keywords

ClinConnect Summary

The Central Line Study is a clinical trial aimed at comparing two different methods for placing a central venous catheter, which is a special type of IV used to give medications or fluids directly into the bloodstream. This study is looking for adult patients aged 65 to 74 who are in the emergency department and need this procedure done with the help of ultrasound guidance. If you or a family member is being treated in the emergency department and meets these age criteria, the medical team will discuss the possibility of participating in the study.

Participants in this trial can expect to be randomly assigned to one of the two techniques for placing the catheter. The goal is to see which method is safer and more effective. It’s important to note that patients with certain medical conditions, such as bleeding disorders or previous central line placements in the same area, may not be eligible to join. The study is still actively recruiting participants, and those who are eligible will be asked to provide informed consent before taking part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients in the emergency department who require ultrasound guided central line placement are eligible for participation and will be referred for participation in the study by the clinical team.
• Exclusion Criteria:
• • Inherited, acquired, or medication related coagulopathy or thrombocytopenia (platelets \< 100,000). Patients will not be excluded for use of aspirin or other anti-platelet medication.
• • Previous central venous access at the same anatomical site.
• • Any indwelling catheter or wire that could potentially interfere with central line placement
• • Anterior border of the target vein deeper than 3.5cm
• • Or for any clinical feature that would interfere with obtaining informed consent including dementia, delirium, or encephalopathy, as determined by the clinical attending physician.